Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro. 1994

Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
Department of Biochemistry, McGill University, Montreal, Quebec, Canada.

Initiation of poliovirus RNA translation by internal entry of ribosomes is believed to require the participation of trans-acting factors. The mechanism of action of these factors is poorly defined. The limiting amount of one of these factors, La protein, in rabbit reticulocyte lysates (RRL) has been postulated to partially explain the inefficient translation of poliovirus RNA in this system. To further characterize La activity in translation and to identify other potential limiting factors, we assayed the ability of La protein as well as purified initiation factors, eIF-2, guanine nucleotide exchange factor (GEF), eIF-4A, eIF-4B, eIF-4F, and eIF-3, to stimulate the synthesis of P1, the capsid precursor protein, in poliovirus type 1 (Mahoney) RNA-programmed RRL. Of the proteins tested, only La, GEF, and to some extent eIF-2 stimulated the synthesis of P1. The enhanced translation of P1 in response to La occurred concomitantly with the inhibition of synthesis of most aberrant polypeptides, resulting from initiation in the middle of the genome. Deletion of the carboxy-terminal half (214 amino acids) of La did not decrease its binding to the poliovirus 5' untranslated region but abrogated the stimulatory and correcting activity in translation. In contrast to La, GEF and eIF-2 stimulated the overall translation and increased the synthesis of aberrant products as well as P1. Neither La, GEF, nor any other factor stimulated translation of encephalomyocarditis virus RNA in RRL. The implications of these findings for the mechanism of internal translation initiation on picornavirus RNAs are discussed.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010442 Peptide Chain Initiation, Translational A process of GENETIC TRANSLATION whereby the formation of a peptide chain is started. It includes assembly of the RIBOSOME components, the MESSENGER RNA coding for the polypeptide to be made, INITIATOR TRNA, and PEPTIDE INITIATION FACTORS; and placement of the first amino acid in the peptide chain. The details and components of this process are unique for prokaryotic protein biosynthesis and eukaryotic protein biosynthesis. Chain Initiation, Peptide, Translational,Protein Biosynthesis Initiation,Protein Chain Initiation, Translational,Protein Translation Initiation,Translation Initiation, Genetic,Translation Initiation, Protein,Translational Initiation, Protein,Translational Peptide Chain Initiation,Biosynthesis Initiation, Protein,Genetic Translation Initiation,Initiation, Genetic Translation,Initiation, Protein Biosynthesis,Initiation, Protein Translation,Initiation, Protein Translational,Protein Translational Initiation
D010448 Peptide Initiation Factors Protein factors uniquely required during the initiation phase of protein synthesis in GENETIC TRANSLATION. Initiation Factors,Initiation Factor,Factors, Peptide Initiation,Initiation Factors, Peptide
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D012156 Reticulocytes Immature ERYTHROCYTES. In humans, these are ERYTHROID CELLS that have just undergone extrusion of their CELL NUCLEUS. They still contain some organelles that gradually decrease in number as the cells mature. RIBOSOMES are last to disappear. Certain staining techniques cause components of the ribosomes to precipitate into characteristic "reticulum" (not the same as the ENDOPLASMIC RETICULUM), hence the name reticulocytes. Reticulocyte
D002474 Cell-Free System A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p166) Cellfree System,Cell Free System,Cell-Free Systems,Cellfree Systems,System, Cell-Free,System, Cellfree,Systems, Cell-Free,Systems, Cellfree
D000097585 SS-B Antigen Nuclear autoantigens implicated in nascent RNA protection. It is a target of AUTOANTIBODIES in patients with SJOGREN'S SYNDROME. LA Antigen,La(SSB) Antigen,Lupus Antigen La,SS-B La Antigen,Sjogren's Syndrome-B Antigen,SS B Antigen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens

Related Publications

Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
May 1984, Journal of virology,
Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
January 1994, Archives of virology,
Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
November 1975, Journal of molecular biology,
Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
August 1988, Journal of virology,
Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
July 1988, Nature,
Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
November 2013, International journal of molecular sciences,
Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
October 1980, Nature,
Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
October 1978, Journal of virology,
Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
January 1989, Journal of virology,
Y V Svitkin, and K Meerovitch, and H S Lee, and J N Dholakia, and D J Kenan, and V I Agol, and N Sonenberg
January 2007, Methods in enzymology,
Copied contents to your clipboard!